兴华创新医疗6个月持有混合发起C(013921)利润分配表
| |
2024-06-30 |
2023-12-31 |
2023-06-30 |
2022-12-31 |
| 收入 |
-4,104,338.76 |
-5,339,490.30 |
-2,788,598.40 |
-5,227,834.02 |
| 利息合计 |
1,462.37 |
4,466.64 |
2,862.83 |
12,448.62 |
| 其中：存款利息收入 |
1,362.18 |
4,466.64 |
2,862.83 |
12,442.24 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
100.19 |
- |
- |
6.38 |
| 投资收益合计 |
-2,749,492.02 |
-8,785,443.07 |
-4,020,147.59 |
-1,784,442.85 |
| 其中：股票投资收益 |
-2,857,163.05 |
-8,988,245.76 |
-4,219,175.87 |
-2,067,914.50 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
3,400.12 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
107,671.03 |
202,802.69 |
199,028.28 |
280,071.53 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-1,356,309.11 |
3,441,486.13 |
1,228,686.36 |
-3,455,839.79 |
| 其他收入 |
- |
- |
- |
- |
| 费用 |
122,242.57 |
424,668.33 |
256,797.67 |
684,208.05 |
| 管理人报酬 |
89,002.59 |
325,986.92 |
197,641.52 |
447,453.63 |
| 基金托管费 |
14,833.82 |
54,331.16 |
32,940.27 |
74,575.58 |
| 销售服务费 |
5,910.72 |
18,733.32 |
10,960.80 |
20,702.79 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
12,495.44 |
25,616.93 |
15,255.08 |
141,476.05 |
| 利润总额 |
-4,226,581.33 |
-5,764,158.63 |
-3,045,396.07 |
-5,912,042.07 |
微信公众号
证券之星APP
基本资料
